Recent studies have reported that activation of PPARβ/δ alleviates dyslipidemia,hyperglycemia, and insulin resistance in animal models of obesity and type 2diabetes [43, 44]. This evidence concerns the gene PPARD and obesity due to melanocortin 4 receptor deficiency.